Axogen

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Axogen and other ETFs, options, and stocks.

About AXGN

Axogen, Inc. engages in the development and market of surgical solutions for peripheral nerve regeneration and repair. It also provides products and education to improve surgical treatment algorithms for peripheral nerve damage or discontinuity. 

CEO
Michael D. Dale
CEOMichael D. Dale
Employees
452
Employees452
Headquarters
Alachua, Florida
HeadquartersAlachua, Florida
Founded
1977
Founded1977
Employees
452
Employees452

AXGN Key Statistics

Market cap
746.42M
Market cap746.42M
Price-Earnings ratio
-152.70
Price-Earnings ratio-152.70
Dividend yield
Dividend yield
Average volume
1.30M
Average volume1.30M
High today
$16.54
High today$16.54
Low today
$16.00
Low today$16.00
Open price
$16.02
Open price$16.02
Volume
1.39M
Volume1.39M
52 Week high
$21.00
52 Week high$21.00
52 Week low
$9.22
52 Week low$9.22

AXGN News

TipRanks 14h
Optimistic Buy Rating for AxoGen Amid Regulatory Delays and Market Potential

AxoGen, the Healthcare sector company, was revisited by a Wall Street analyst on August 25. Analyst Mike Kratky from Leerink Partners maintained a Buy rating on...

Benzinga 3d
FDA Pushes Back Axogen Avance Nerve Graft Decision By 3 Months

The U.S. Food and Drug Administration (FDA) on Monday extended the Prescription Drug User Fee Act (PDUFA) goal date for Axogen Inc.’s AXGN Biologics License App...

FDA Pushes Back Axogen Avance Nerve Graft Decision By 3 Months
Seeking Alpha 3d
Axogen falls 16% after FDA delays Avance Nerve Graft decision to December

Healthcare On the Move Axogen falls 16% after FDA delays Avance Nerve Graft decision to December Aug. 25, 2025 7:07 AM ET Axogen, Inc. (AXGN) Stock By: Arundha...

Axogen falls 16% after FDA delays Avance Nerve Graft decision to December

Analyst ratings

100%

of 9 ratings
Buy
100%
Hold
0%
Sell
0%

More AXGN News

Simply Wall St 5d
When Can We Expect A Profit From Axogen, Inc.?

With the business potentially at an important milestone, we thought we'd take a closer look at Axogen, Inc.'s ( ) future prospects. Axogen, Inc., together with...

When Can We Expect A Profit From Axogen, Inc.?

People also own

Based on the portfolios of people who own AXGN. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.